Health Condition 1: L80- Vitiligo
Conditions
Interventions
None listed
Sponsors
Department of Dermatology, Venereology and Leprosy, Government Medical College, Srinagar
Eligibility
Inclusion criteria
Inclusion criteria: Age group 12-65 years. Age and sex matched apparently healthy controls. Patients with non-segmental vitiligo. Both males and females will be included.
Exclusion criteria
Exclusion criteria: Patients receiving systemic treatment in the last 3 months. Patients receiving narrow band phototherapy (NB UVB). Patients with any autoimmune disorder such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, systemic lupus erythematosus, patients with type 1 and 2 diabetes mellitus and thyroid disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimation of Serum levels of CXCL10 in patients and controls.Timepoint: Estimation of Serum CXCL10 Levels, use of dermoscopy in detection of vitiligo activity and stability, vitiligo disease activity score (VIDA),at baseline.Patients will be followed up every 4 weeks, for 16 weeks. At each follow up,VIDA Score and dermoscopy will be done. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Estimation of serum CXCL10 Levels in patients & controls 2.VIDA SCORE 3.VASI SCORE 4.Dermoscopic Examination of vitiligo to assess the activity of disease.Timepoint: Estimation of Serum CXCL10 Levels, use of dermoscopy in detection of vitiligo activity & stability, vitiligo disease activity score (VIDA),at baseline.Patients will be followed up every 4 weeks, for 16 weeks. At each follow up,VIDA Score & dermoscopy will be done. | — |
Countries
India
Contacts
Public ContactDr Ishrat binti ismail
Department of Dermatology, Venereology and Leprosy, Government Medical College, Srinagar
Outcome results
None listed